C

CUE

Cue Biopharma Inc

37.05

-0.79-2.09%
Pre Market: 47.21  +10.16  +27.42%05:59 09/21 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE38.50/37.05
TODAY RANGE25.00-41.50
VOL2.03M
MARKET CAP188.66M
52 WEEK RANGE4.971-45.50
AVG VOL (3M)170.04K
% TURNOVER27.90%
TURNOVER--
P/E (TTM)-0.9621
% RANGE44.53%
EPS(TTM)-26.9925
P/E(FORWARD)-1.0384
P/B58.80
BVPS0.4417
DIVIDEND--
P/S3.045
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP170.36M
SHARES OUTSTANDING7.26M
NEXT EARNINGS11/10-11/16
FREE FLOAT6.56M
LOT SIZE1
EX-DATE04/24/2026
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

C

Cue Biopharma Inc

CUE

-2.09%
37.05

REGN

--

G

GridAI Tech

GRDX

+2.98%
3.110

B

BIONTECH

BNTX

+1.73%
97.72

聯合治療

UTHR

-0.53%
494.63

SIGA

--

V

Vertex Pharmaceuticals Inc

VRTX

-1.55%
508.34

M

Moderna

MRNA

-2.55%
154.04

CRL

--

MEDP

--

TLPH

--

I

ICON plc

ICLR

-3.28%
164.11

CBPO

--

IQV

--

M

MOLECULAR PARTNERS AG

MOLN

+7.40%
4.210

P

PRA健康科學

PRAH

0.00%
165.21

A

Arcturus醫療

ARCT

-5.32%
16.03

GILD

--

APVO

--

INCY

--

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.